Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

ARIAD Pharmaceuticals, Inc. announced that it intends to offer, subject to market and other conditions, 17,000,000 shares of its common stock in an underwritten public offering. ARIAD expects to grant the underwriters a thirty–day option to purchase up to 2,550,000 additional shares to cover over–allotments, if any.

Today in Popular Press...keeping you current

A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09

Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09

Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address